Zhong Guo Jing Ji Wang
Search documents
智翔金泰连亏5年 2023年上市募资34.7亿元
Zhong Guo Jing Ji Wang· 2026-02-02 02:49
中国经济网北京2月2日讯 智翔金泰(688443.SH)日前披露2025年年度业绩预告。经财务部门初步测 算,公司预计2025年年度实现营业收入20,944.98万元到25,087.94万元,与上年同期相比增加17,935.48万 元到22,078.44万元,同比增长595.96%到733.62%。 公司预计2025年年度归属于母公司所有者的净利润为-48,063.73万元到-58,744.56万元,与上年同期 相比,亏损减少20,982.80万元到31,663.63万元,同比减少26.32%到39.71%;归属于母公司所有者扣除 非经常性损益后的净利润为-52,363.18万元到-63,044.01万元,与上年同期相比,亏损减少17,388.95万元 到28,069.78万元,同比减少21.62%到34.90%。 2021年至2024年,智翔金泰归属于上市公司股东的净利润分别为-3.22亿元、-5.76亿元、-8.01亿 元、-7.97亿元;归属于上市公司股东的扣非净利润分别为-3.34亿元、-6.45亿元、-8.13亿元、-8.04亿 元。 智翔金泰于2023年6月20日在上交所科创板上市,公开发行新股9 ...
工银盈泰稳健6个月持有混合FOF成立 规模45.8亿元
Zhong Guo Jing Ji Wang· 2026-02-02 02:36
| 基金募集申请获中国证监会核准的文号 | | 证监许可【2025】2479号 | | --- | --- | --- | | 基金享集期间 | | 自2026年1月19日至2026年1月28日止 | | 验资机构名称 | | 安永华明会计师事务所(特殊普通合伙) | | 募集资金划入基金托管专户的日期 | | 2026年1月30日 | | 募集有效认购总户数(单位:户) | | 17.713 | | 募集期间净认购金额(单位:人民币元) | | 4.579.722.904. 77 | | 认购资金在募集期间产生的利息(单位:人 | | 822, 947, 19 | | 民币元) | | | | 有效认购份额 | | 4.579.722.904. 77 | | 募集份額(单位:份) | 利息结转的份额 | 822, 947. 19 | | 合计 | | 4.580.545.851.96 | 中国经济网北京2月2日讯 近日,工银瑞信基金发布工银瑞信盈泰稳健6个月持有期混合型基金中基 金(FOF)基金合同生效公告。 募集期间净认购金额4,579,722,904.77元,认购资金在募集期间产生的利息822,947. ...
鹏华基金祝松:把握“固收+”权益结构性机会,聚焦“周期+消费细分+新能源”三大方向
Zhong Guo Jing Ji Wang· 2026-02-02 02:03
权益市场方面,祝松认为,积极的政策取向将为宏观经济合理增长保驾护航,进而为权益市场提供坚实 支撑。结构上,受益于政策支持的周期、内需等方向,有望迎来较好机会。 2026年作为"十五五"规划的开局之年,宏观经济与市场走势备受关注。鹏华基金债券投资一部总经理、 拥有18年公募投资经验的基金经理祝松,基于宏观研判与实战积累,对新年市场及"固收+"策略作出深 入分析。他指出,2026年"固收+"领域机遇整体大于挑战,关键在于把握权益资产的结构性机会,重点 关注下行风险有限、上行弹性较足的板块,例如周期领域的金融、建筑、建材、化工,部分消费细分赛 道,以及受益于"反内卷"政策支持的新能源等方向。 债券市场方面,祝松判断,货币政策仍将保持适度宽松,债券利率大幅上行的可能性较低;但政策利率 下调空间有限,叠加"反内卷"等政策可能抬升通胀中枢,债市整体或呈现小幅震荡格局。 "固收+"机遇占优,三维策略把握机会 消费与投资双轮驱动,关注外部与地产风险 祝松认为,2026年国内宏观经济增长的核心支撑将来自消费增长与投资企稳。消费端,自2024年以来国 家通过"两新"、"国补"等政策持续刺激内需,2025年中央经济工作会议进一步明 ...
AI承诺生成内容有误将赔偿,算数吗?
Zhong Guo Jing Ji Wang· 2026-02-02 01:59
Core Viewpoint - The Hangzhou Internet Court has adjudicated the first case in China regarding infringement disputes caused by "hallucinations" from generative artificial intelligence models, clarifying the responsibility boundaries for AI services [1] Group 1: AI Liability and Responsibility - The court ruling indicates that AI-generated content can mislead users, raising questions about whether this constitutes infringement and the extent of the service provider's liability [1][2] - In the case, the AI claimed it would compensate users 100,000 yuan for incorrect content, which led to disputes; however, the court clarified that such promises do not represent the platform's intent [2] - The ruling establishes that AI does not possess civil subject status, meaning AI-generated compensation promises are not legally binding unless explicitly set by the service provider [3] Group 2: Obligations of AI Service Providers - According to the "Interim Measures for the Management of Generative AI Services," generative AI services fall under the service category, imposing strict review obligations on service providers [4] - Service providers must take immediate action to stop the generation or transmission of illegal content and implement corrective measures, such as model optimization training [4] - Providers are also required to prominently warn users about the potential inaccuracies of AI-generated content to prevent undue reliance [4]
今日申购:易思维、爱得科技
Zhong Guo Jing Ji Wang· 2026-02-02 01:56
Group 1: Company Overview - Yisiwei (Hangzhou) Technology Co., Ltd. focuses on the research, production, and sales of machine vision equipment for automotive manufacturing, providing solutions for various processes in vehicle and component manufacturing [2] - The company is controlled by Guo Yin, who directly holds 12.27% of the shares and indirectly controls a total of 56.13% of the company through various entities [3] Group 2: IPO Details - Yisiwei plans to raise approximately 1.214 billion yuan for projects including the industrialization base for machine vision products, a research and development center, and to supplement working capital [3] - The company is set to issue 25 million shares at a price of 55.95 yuan per share, with an expected total fundraising amount of 1.399 billion yuan, resulting in a net amount of approximately 1.282 billion yuan after deducting issuance costs [3]
241只ETF获融资净买入 易方达中证香港证券投资主题ETF居首
Zhong Guo Jing Ji Wang· 2026-02-02 01:49
Group 1 - The total margin balance of ETFs in the Shanghai and Shenzhen markets as of January 30 is 120.251 billion yuan, a decrease of 2.896 billion yuan from the previous trading day [1] - The financing balance of ETFs is 112.88 billion yuan, down by 2.767 billion yuan, while the margin balance for securities lending is 7.371 billion yuan, a decrease of 0.129 billion yuan [1] - On January 30, 241 ETFs experienced net financing inflows, with the E Fund CSI Hong Kong Securities Investment Theme ETF leading with a net inflow of 84.1736 million yuan [1] Group 2 - Other ETFs with significant net financing inflows include the Huaxia Hang Seng Internet Technology ETF, the FTSE China A50 ETF, the Huabao CSI Medical ETF, the Bosera Gold ETF, and the Huaan Gold ETF [1]
鹏华基金王石千:科技与资源主线明确,构建多元“固收+”产品生态
Zhong Guo Jing Ji Wang· 2026-02-02 01:49
2025年以来,公募基金市场结构性增长显著,"固收+"产品凭借稳健与弹性兼具的特性,成为资金配置 的核心选择。鹏华基金多元资产投资部总经理、基金经理王石千管理的"固收+"产品线表现突出。据基 金定期报告,截至2025年末,王石千管理的"固收+"产品总规模已达451.10亿元。其中,二级债基鹏华 双债加利(A类000143)2025年规模激增超184亿元,这既是市场对其策略的认可,也印证了投资者对"固 收+"产品的迫切需求。 展望2026年,王石千认为,权益资产仍然面临较好的投资机会,科技和资源两大主线将贯穿始终,灵活 配置以捕捉结构性机会。 科技与资源主线明确,内需复苏成关键变量 在王石千看来,2026年股票市场或仍处于牛市进程,核心驱动力明确且多元。人工智能产业趋势作为全 球市场主线,有望保持持续投资机会。同时,美元信用削弱背景下,人民币资产吸引力提升,中国股市 可能重新吸引外资流入,叠加居民存款持续增长、传统资产收益下行,股市吸引力相对提升。 与此同时,宏观层面也存在需要关注的风险点。王石千表示,国内物价走势及内需板块的复苏强度,将 成为影响权益市场行情大小的关键因素。若政策能有效推动供给侧优化与需求侧提 ...
人民币对美元中间价报6.9695 下调17个基点
Zhong Guo Jing Ji Wang· 2026-02-02 01:49
(责任编辑:马欣) 中国经济网北京2月2日讯 来自中国外汇交易中心的数据显示,今日人民币对美元汇率中间价报6.9695, 较前一交易日下调17个基点。 中国人民银行授权中国外汇交易中心公布,2026年2月2日银行间外汇市场人民币汇率中间价为:1美元 对人民币6.9695元,1欧元对人民币8.2651元,100日元对人民币4.4926元,1港元对人民币0.89249元,1 英镑对人民币9.5385元,1澳大利亚元对人民币4.8430元,1新西兰元对人民币4.1916元,1新加坡元对人 民币5.4759元,1瑞士法郎对人民币9.0099元,1加拿大元对人民币5.1098元,人民币1元对1.1546澳门 元,人民币1元对0.56557马来西亚林吉特,人民币1元对10.9237俄罗斯卢布,人民币1元对2.3227南非兰 特,人民币1元对208.04韩元,人民币1元对0.52681阿联酋迪拉姆,人民币1元对0.53803沙特里亚尔,人 民币1元对46.0801匈牙利福林,人民币1元对0.50968波兰兹罗提,人民币1元对0.9035丹麦克朗,人民币 1元对1.2784瑞典克朗,人民币1元对1.3836挪威克朗,人民币1 ...
告别“尚不明确”!头部药企早已布局这场“中药合规赛”
Zhong Guo Jing Ji Wang· 2026-02-02 01:29
Core Insights - The pharmaceutical industry is approaching a critical juncture with the impending implementation of the "Traditional Chinese Medicine Registration Management Regulations" by July 1, 2026, which will require clarity in drug labeling and safety information [1][2] Industry Overview - The "life and death clause" for traditional Chinese medicine (TCM) was officially implemented on July 1, 2023, mandating that any drug label containing "unclear" information regarding contraindications, adverse reactions, or precautions will not be re-registered after the three-year grace period ending on July 1, 2026 [2] - As of the end of 2025, there are approximately 57,000 valid TCM approval numbers in China, with over 40,000 of these lacking clear safety information, indicating a significant challenge for many products [2] Safety and Quality Transition - Concerns regarding the safety of TCM have been addressed by experts, highlighting that TCM accounts for only 12% of reported adverse drug reactions over the past five years, compared to 81% for chemical drugs, suggesting that TCM is relatively safe [3] - The new regulations aim to enhance the quality of TCM by transitioning from a focus on quantity to prioritizing quality, thereby improving the clarity and evidence-based nature of drug usage [3] Company Responses - Leading companies in the TCM sector, such as Yiling Pharmaceutical, have proactively revised their product labels to comply with the new regulations, ensuring that all necessary safety information is clearly stated [4] - Other companies like Rongchang Pharmaceutical and Buchang Pharmaceutical have also completed the necessary updates to their product descriptions, indicating a strong industry response to the regulatory changes [4] - The upcoming deadline is seen as an opportunity for compliant companies to strengthen their market position by eliminating lower-quality competitors, marking a shift towards responsible and high-quality development in the TCM industry [4]
银行理财市场热度不减 存续规模增长11.15%
Zhong Guo Jing Ji Wang· 2026-02-02 00:42
面对大量资金涌入,理财公司在资产端面临更多机遇和挑战。一方面,新质生产力蓬勃发展、"南向通"扩容 等为理财行业提供了优质投资标的;另一方面,随着广谱利率持续下行,固收类资产收益随之回落,传统高 收益资产供给面临收缩。中银理财表示,在此背景下,要平衡好客户期望稳健收益和优质资产稀缺的矛盾, 一是要推动投资范式从"资产引领"向"策略引领"转变,减少对单一品类资产、单一赛道红利的依赖,搭建多 元策略池;二是要做好客户精细化分层,以客户风险偏好和收益目标为导向,匹配相应的策略组合。 年关将至,银行理财市场热度不减。随着存款利率下行,不少低风险偏好资金向银行理财迁徙。 1月23日,银行业理财登记托管中心发布的《中国银行业理财市场年度报告(2025年)》显示,截至2025年 末,银行理财市场存续规模33.29万亿元,较年初增长11.15%;全年累计新发理财产品3.34万只,募集资金 76.33万亿元。其中,固定收益类产品存续规模为32.32万亿元,占全部理财产品存续规模的97.09%;风险等 级为二级(中低)及以下的理财产品存续规模为31.87万亿元,占全部理财产品存续规模的95.73%。 上海金融与发展实验室首席专家、 ...